Clinical Trial Update: Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating gemcitabine plus radiation therapy for pancreatic cancer has completed. No trial results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemzar) (gemcitabine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED